Certolizumab Subcutaneous and Moxetumomab pasudotox
Determining the interaction of Certolizumab Subcutaneous and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: certolizumab
Brand name: Cimzia, Cimzia Starter
Synonyms: Certolizumab, Certolizumab Pegol
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Certolizumab Subcutaneous-Moxetumomab Pasudotox-tdfk
- Certolizumab Subcutaneous-Moxetumomab pasudotox-tdfk Intravenous
- Certolizumab Subcutaneous-Moxifloxacin
- Certolizumab Subcutaneous-Moxifloxacin (Systemic)
- Certolizumab Subcutaneous-Moxifloxacin Hydrochloride
- Certolizumab Subcutaneous-Moxifloxacin Injection
- Moxetumomab pasudotox-Certolizumab Vials
- Moxetumomab pasudotox-Cerubidine
- Moxetumomab pasudotox-Cervarix
- Moxetumomab pasudotox-Cervarix Intramuscular
- Moxetumomab pasudotox-Cervidil
- Moxetumomab pasudotox-Cesamet